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Summary 
Object: To determine whether diacerhein has a disease-modifying effect in an accelerated canine model of 
osteoarthritis. 
Design: Fourteen adult mongrel dogs underwent unilateral L4-$1 dorsal root ganglionectomy (DRG), followed 3 
weeks later by ipsilateral anterior cruciate ligament ransection. Seven dogs received iacerhein (15-20 mg/kg) daily 
throughout the interval between DRG and sacrifice, eight weeks after ligament ransection. The other seven dogs 
served as OA controls. 
Results: The mean volume of synovial fluid obtained from the OA knee of the diacerhein-treated dogs was 
approximately 40% less than that from the OA knee of the controls. In addition, diacerhein appeared to reduce the 
severity of fibrillation (femoral condyle) and full-thickness ulceration (trochlear ridge) of the articular cartilage and 
the level of collagenase activity in extracts of the OA cartilage, and to increase net PG synthesis in the OA cartilage, 
although none of the above changes were statistically significant. 
Conclusion: The differences between the diaeerhein group and untreated OA controls, even though not statistically 
significant, suggest hat diacerhein was active in this rapidly progressive model of OA. Because changes associated 
with initiation of OA may be different than those associated with progression, whether diacerhein has a 
disease-modifying effect should be examined in a less rapidly progressive model. 
Key words: Diacerhein, Osteoarthritis, Animal model, Articular cartilage. 
Introduction 
PHARMACOLOGIC treatment of osteoarthrit is (OA) 
today is only palliative; i.e., it is employed with the 
objective of relieving joint pain and improving 
mobility, and is based chiefly on the use of 
analgesics and nonsteroidal anti- inflammatory 
drugs (NSAIDs) [1]. On the other hand, a variety of 
agents which are neither primary analgesics nor 
NSAIDs have been shown to prevent he develop- 
ment of OA or to slow the progression of 
established pathologic hanges in the OA joint in 
animal models [2]. These agents have been 
designated isease modifying OA drugs (DMOADs) 
[3]. To date, however, no agent has convincingly 
been demonstrated to have a DMOAD effect in 
well-controlled clinical trials in humans. 
Several animal models have been used to study 
DMOADs. In some, OA is produced by mechanical 
alteration of the joint (e.g., meniscectomy [4], 
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cruciate l igament ransection [5]). In others, joint 
damage is produced chemically (e.g., by intra-artic- 
ular injection of proteolytic enzymes or metabolic 
poisons [6-8]. In yet other models, development of 
OA is spontaneous (e.g., Hart ley strain guinea-pigs 
[9] and some strains of mice [10]). Perhaps the 
most widely util ized animal model of OA is 
the cruciate-deficient dog, in which morphologic, 
biochemical and metabolic hanges develop in the 
unstable joint which mimic those of human OA 
[11]. Although changes in art icular carti lage of the 
unstable knee typically remain relatively mild 
for 3 years or more, the disease is progressive; 
eventually, full-thickness loss of art icular carti- 
lage develops on the bearing surfaces of the joint 
[12]. However, progression of OA in the cruciate- 
deficient dog is markedly accelerated if sensory 
input from the ipsilateral hindlimb is reduced (e.go, 
by art icular nerve neurectomy or L4-$1 dorsal root 
ganglionectomy) 2-3 weeks prior to transect ion of 
the cruciate l igament [13]. Under those conditions, 
full-thickness loss of art icular cart i lage may be 
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seen within only weeks, rather than requiring 
years, as in the neurologically intact cruciate- 
deficient dog. This accelerated crueiate deficiency 
model has been used recently to demonstrate he 
DMOAD effect of doxycycline [14, 15]. 
Diacerhein, the aeetylated form of the an- 
thraquinone, rhein, has no effect on phospholipase 
A2, cyelo-oxygenase or 5 lipoxygenase, but has 
been shown to stimulate synthesis of prostaglandin 
E2 (PGE2) by chondroeytes in culture and to inhibit 
expression of collagenase by chondrocytes xposed 
to interleukin-1 (IL-1) [16-21]. Clinical studies have 
suggested that diacerhein has a beneficial effect on 
the symptoms of OA, although benefit is usually 
not observed before the first month of therapy 
[22 24]. Diacerhein is marketed in France by 
Negma as ART 50 '~, for symptomatic treatment of 
OA. Furthermore, administration of diaeerhein 
has been reported to protect against he develop- 
ment of contusion-induced OA in rabbits [25]. 
Diacerhein is currently under evaluation as a 
DMOAD in randomized placebo-controlled clinical 
trials of patients with OA of the hip and OA of the 
knee. The present study was designed to examine 
the possibility that diaeerhein exhibits DMOAD 
activity in the accelerated canine erueiate-defi- 
ciency model of OA. 
Mater ia ls  and Methods  
SURGICAL  PROCEDURES 
Fourteen adult male mongrel dogs (25-30 kg 
body weight) were employed in this study. 
Radiographs of both hindlimbs of each dog were 
reviewed at baseline to assure that the epiphyses 
were closed and to exclude pre-existing joint 
pathology. In accordance with guidelines of the 
Indiana University School of Medicine Animal 
Care and Use Committee ach dog underwent left 
L4-$1 dorsal root ganglionectomy (DRG), followed 
3 weeks later by transection of the anterior 
cruciate ligament of the ipsilateral knee (ACLT). 
The surgical procedures were performed exactly as 
described previously [26]. After recovery from 
surgery, each dog was transferred to a spacious 
pen (1.8x 1.8x 1.8 m) in which it could ambulate 
freely. Eight weeks after ACLT, the dogs were 
killed by lethal injection of a barbituric acid 
derivative, (Beuthanasia-D, Schering-Plough Ani- 
mal Health Corporation, Kenilworth NJ, U.S.A.). 
ADMINISTRATION OF D IACERHEIN 
Seven dogs received iacerhein and seven served 
as untreated controls. Diacerhein treatment began 
on the day after DRG, in a daily dose of 15 mg/kg 
bid. Administration of the drug, which was 
formulated as a powder, was facilitated by 
incorporating each dose into a meatball. One 
month after the onset of treatment of the first six 
animals, the daily dose of diacerhein was increased 
to 20mg/kg bid; dog 7 in the diacerhein group 
inadvertently received 20mg/kg bid throughout 
the treatment period. 
PROCUREMENT OF SYNOVIAL  FLUID AND TISSUES 
Immediate ly  after sacrifice, both knees of each 
dog were opened aseptically and the synovial fluid 
was  removed as completely as possible with a 
syringe. The  vo lume of fluid was  recorded and a 
sample was  taken for determination of the total 
white cell count and differential. 
The  distal femur and proximal tibia of each knee 
were  removed with a bone saw, following wh ich  
each was  promptly photographed and placed in 
cold sterile Ham's  F-12 culture med ium.  Samples  of 
synov ium from the infrapatellar pad and suprap- 
atellar pouch  and were placed in I0% formalin 
for subsequent histological examination. A full- 
thickness section of articular cartilage from 
the central weight-bearing region of the medial  
femoral condyle (10-15 mg wet weight) was  
removed for determination of water content and 
uronic acid concentration. A strip, 0.5 cm wide, of 
the adjacent cartilage and underlying subchondral  
bone, extending from the femoral notch to the 
outer edge of the medial  femoral condyle, was  
removed with a bone saw for histological and  
histochemical examination. The  remainder  of the 
cartilage on the weight-bearing surface of the 
medial  femoral condyle and all of the cartilage on 
the weight-bearing region of the lateral femoral 
condyle was  shaved with a scalpel into slices less 
than 0.5 mm thick and placed in organ culture for 
studies of proteoglycan (PG) synthesis. Cartilage 
from the bare areas of the medial and lateral tibial 
plateau of each knee (i.e., the regions not covered 
by meniscus) was  removed with a scalpel for assay 
of metalloproteinase (MMP)  activity. 
DETERMINATION OF THE NET RATE OF PG SYNTHESIS  
The cartilage slices from each joint (approx. 
60-90 rag) were pooled and transferred in triplicate 
to culture dishes for determination f net 3'5SO4-PG 
synthesis, essentially as described previously [27]. 
Ham's F12 medium (3 ml), supplemented with 10% 
newborn calf serum, penicillin (100 U/ml), strepto- 
mycin (100 mg/1), amphotericin-B (250 mg/1, Gibco, 
Grand Island, NY, U.S.A.), L-ascorbic acid (50 rag/l) 
440 Brandt  et a l . :  Diacerhe in  in can ine  osteoarthr i t i s  
and bovine serum albumin (5 mg/1), was added to 
each culture dish. The samples were then 
incubated for 20h at 37 ~ C in 95% air/5% CO2, 
following which the medium was removed and 
was replaced with fresh medium containing 
Na23~SO4 (20~Ci/ml) and the incubation was 
continued for an additional 4 h. The dishes were 
then placed on ice, the medium was removed, and 
the cartilage was rinsed with 3 ml cold medium. 
The rinse was added to the spent medium and the 
sample was then dialyzed against water in 
Spectrapor #3 dialysis tubing (approx. molecular 
weight cut-off=3500; Spectrum Medical Indus- 
tries, Inc., Los Angeles CA, U.S.A.) at 4~ for 72 h 
until a background level of radioactivity was 
reached. 
After removal of the medium the rinsed cartilage 
samples were blotted gently, weighed and digested 
overnight at 56~ with pronase (1 mg/ml) in 0.05 m 
Tris hydroxymethylaminomethane, pH 8.0, follow- 
ing which the digests were dialyzed as described 
above. Net  PG synthesis was determined by 
counting an aliquot of each sample in a liquid 
scintillation spectrometer. The results were ad- 
justed for differences in volume and in wet weight 
of the cartilage. 
BIOCHEMICAL ANALYSES 
The samples of articular cartilage from the 
central weight-bearing surface of the medial 
femoral condyle were immediately blotted gently 
with Whatman # 1 filter paper, weighed and placed 
in acetone. The acetone was changed twice over 
the next 24 h, following which the samples were 
dried to constant weight at 80~ The dry cartilage 
was then digested with pronase, as described 
above, following which the glycosaminoglycans i  
the digest were converted to their sodium salts 
with Bio Rad AG 50• (Na+) cation exchange 
resin. After the resin was removed by filtration the 
uronic acid concentration of the glycosaminogly- 
cans was determined by a modified carbazole 
reaction [28]. 
MMP ASSAYS 
The samples of tibial plateau cartilage from each 
joint were weighed, pulverized in liquid nitrogen 
and suspended (150 mg/ml) in extraction buffer 
(50 mM Tris-HC1, 10 mM CaC12, 2 m guanidine HC1, 
pH 7.5) [29]. The mixture was stirred overnight at 
4~ following which it was centrifuged for 30 min 
at 21 000 rpm, and the supernatant was dialyzed 
against three changes of assay buffer (50 mM 
Tris HC1, 10 mM CaCL2, 0.2 M NaC1, 0.05% Brij 35, 
0.02% sodium azide, pH7.5) [17,18,29]. MMP 
activities were determined after selective destruc- 
tion of tissue inhibitors of metalloproteinases 
(TIMP) by reduction and alkylation [30, 31]. Using 
cartilage from this canine model of OA, we have 
previously found that MMP activity is not 
detectable without prior destruction of TIMP. In 
the present study we confirmed this observation on 
selected samples of cartilage. In each of the MMP 
assays, therefore, we assayed total (latent plus 
active) MMP activity after the destruction of 
TIMP, as follows: 
Briefly, the extract was incubated at 
37~215 with 2mM dithiothreitol. Iodoac- 
etamide (5 raM) was added and the incubation was 
continued for an additional 30min at 37~ 
following which these reagents were removed by 
overnight dialysis against assay buffer at 4~ This 
procedure has no effect on the MMPs and destroys 
TIMP before it can complex with the proteinases 
in the crude extracts of cartilage. 
COLLAGENASE 
Purified collagen from rat tail tendon was 
acetylated with 14C-acetic anhydride [32], dissolved 
in 0.5 M acetic acid and dialyzed against 0.01 M 
Tris-HC1, 0.2 m NaC1, pH 7.5, before use in the 
assay. For the collagenase assay, the substrate was 
incubated in assay buffer (see above) for 2 h at 37~ 
to allow fibrils to form. Samples of the cartilage 
extract were added to the preformed fibrils and 
incubated for 20 h at 37~ after which the mixture 
was centrifuged for 10min at room temperature 
and the radioactivity in an aliquot of the 
supernatant was determined in a scintillation 
counter. The assays were performed in a total 
volume of 100 ~tl with enzyme extract plus 1 mm 
aminophenylmercuric acetate (APMA) (to measure 
active plus latent collagenase), or with enzyme 
extract plus 1 mm APMA and 0.01 M 1,10 phenan- 
throline (to control for non-MMP solubilization of 
collagen). Blank tubes containing only labeled 
collagen and assay buffer were prepared for each 
assay, and the blank value was subtracted from 
assay results. 
GELATINASE 
Aliquots of the collagenase substrate (see above) 
were denatured by heating at 100~ for 3 rain and 
were then used to assay gelatinase [33]. The assay 
mixture contained 0.13 ~g of labeled gelatin and 
50 ~d of extract in a final volume of 200 ~1. Total 
enzyme was measured in the presence of APMA, 
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and non-MMP gelatinase activity was measured in 
the presence of APMA and 1,10 phenanthroline. 
Blank tubes containing only labeled gelatin and 
assay buffer were prepared for each assay. The 
mixture was incubated for 18 h at 37~ following 
which it was placed on ice and 7% sodium 
tungstate and 15% trichloroacetic a id (TCA) were 
added to precipitate the undigested gelatin. The 
samples were allowed to stand for 20min, 
following which they were centrifuged for 10 min 
at 4 ~ and an aliquot of the supernatant was 
counted. 
STROMELYSIN 
Neutral MMP activity was assessed using 
3H-carboxymethylated transferrin as substrate 
[34]. The extraction and incubation conditions 
were identical to those described above for 
collagenase. Following incubation, the undigested 
transferrin was precipitated with 3.3% TCA 
and the 3H-cpm in the supernatant were deter- 
mined. 
HISTOLOGY 
Samples of synovium were fixed in formalin, 
placed in paraffin blocks, sectioned (4 pm) and 
stained with hematoxylin and eosin (H&E). 
Specimens of synovium from the suprapatellar 
pouch and infrapatellar fat pad were examined 
separately. Synovitis was graded in three randomly 
selected sections of suprapatellar synovium as 
described earlier [35], on the basis of the number 
of mononuclear cell nuclei per unit area. One side 
of a square (0.05 x0.05 mm) was aligned with the 
synovial surface and the number of nuclei visible 
within the square was counted. The mean 
cellularity of each specimen was calculated from 
measurements made at three adjacent sites. The 
sections of synovium from the suprapatellar 
pouch, as well as three randomly selected sections 
of synoviuln from the infrapatellar fat pad, 
were also examined for the presence of cartilage 
shards. 
The samples of articular cartilage and under- 
lying subchondral bone taken from the central 
weight-bearing region of the medial femoral 
condyle were fixed, decalcified with Decalcifer I 
solution (Surgipath Medical Industries, Inc., 
Greyslake, IL, U.S.A.) and embedded in paraffin, 
following which sections (5 iLm) were cut perpen- 
dicular to the surface and stained with H&E or 
with Safranin-O fast green. The severity of OA was 
graded according to the criteria of Mankin et. al. 
[36]. 
STATISTICAL ANALYSIS 
The statistical significance of differences be- 
tween the two treatment groups was determined 
using Student's t test unless the distribution of the 
data differed significantly from normal, in which 
case nonparametric statistics (Wilcoxon test) were 
used. A difference of P_< 0.05 was considered 
significant. 
Resu l ts  
For the first 7-10 days after DRG the dogs did not 
bear full lo/id on the ipsilateral hindlimb. During 
this period the paw of the deafferented limb 
generally did not contact he floor and when the 
dog sat or stood the deafferented limb was usually 
maintained in an awkward posture. However, by 4 
weeks after ACL transection, all dogs bore load on 
the unstable knee. In every dog, the neurosurgical 
procedure resulted in loss of the ipsilateral 
patellar eflex and marked, albeit incomplete, loss 
of the response to pin-prick over the ipsilateral 
paw and posterior leg. 
All of the dogs tolerated diacerhein without 
difficulty. The dose of 20 mg/kg bid was associated 
with loose stools, but none of the animals 
developed diarrhea, which has been seen with 
administration of higher doses to dogs (Ficheux, 
H., personal communication). At death, the mean 
body weight of the dogs that received iacerhein 
was 7.1% greater than their mean weight at the 
time of DRG (i.e., 11 weeks earlier), while that of 
the dogs in the control group was 9.0% greater at 
death than at the time of DRG (P= NS). 
SYNOVIAL EFFUSION 
An effusion was present at death in the OA knee 
of every dog in this study (Table I). The mean 
volume of synovial fluid obtained from the OA 
knee of the diacerhein-treated dogs was approxi- 
mately 40% smaller than that obtained from the 
OA knee of the controls (17.1 + 12.1 ml; 
27.3 + 16.0 ml, respectively), although the differ- 
ence was not statistically significant. The volume 
of synovial fluid obtained from the contralateral 
knee was invariably less than 1 ml. 
No difference was noted between treatment 
groups, with regard to the mean leukocyte count in 
synovial fluid from the OA knee, which was 
generally less than 1000 cells/mm :3 (Table I). In dog 
8 in the untreated group the magnitude of synovial 
fluid leukocytosis was highly atypical--16000 
cells/ram ~(Table I). If the results obtained on the 
sample from this dog are deleted from the analysis, 
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the mean synov ia l  f luid leukocyte  count  for 
the unt reated  OA dogs was 625 _+ 420 ce l l s /mm a, 
i.e., s l ight ly  lower  than  that  for the DAR- t reated  
dogs. The vo lume of synov ia l  ef fusion in the OA 
knee of dog 8 (approx imate ly  7 ml), however ,  was 
lower  than  that  obta ined  from any of the  o ther  
dogs in the  study.  A l though a cu l ture  was not  
obta ined ,  the  d i f ferent ia l  count  revea led  that  on ly  
22% of the  cel ls  were po lymorphonuc lear  leuko-  
cytes, a rgu ing  aga ins t  acute  bacter ia l  j o in t  
infect ion.  
SYNOVIAL  MEMBRANE 
Synov ium from the OA knee  of the d iacerhe in -  
t reated  dogs was gross ly  ind is t ingu ishab le  f rom 
that  of samples  from the OA knee of  the unt reated  
dogs. In a l l  cases i t  was hyper t roph ic  and  
hyperemic ,  w i th  prominent  vi l l i .  On h is to log ic  
examinat ion ,  v i l l i  were prominent  and l in ing  cel l  
hyperp las ia  nd  mononuc lear  cel l  in f i l t ra t ion  were 
observed.  The mean mononuc lear  cel l  count  in 
samples  of OA synov ium from the  d iacerhe in -  
t reated  dogs was 6100 • 3100 cel ls per  mm 2. The 
va lue  was somewhat  h igher  (6800 _+ 3300 cel ls  per  
mm 2) in OA synov ium from the  unt reated  an imals  
(P= NS, Tab le  I). Notab ly ,  synov ium from dog 8, 
the an imal  in the unt reated  group  in wh ich  the 
synov ia l  f luid ana lys i s  showed an a typ ica l ly  h igh  
level  of leukocytos i s  (see above),  exh ib i ted  greater  
in f i l t ra t ion  wi th  mononuc lear  cel ls than  any o ther  
sample  of synov ium from the  unt reated  OA dogs. 
However ,  th is  degree of  mononuc lear  cel l  inf i l t ra-  
t ion  was seen also in one an imal  in the 
DAR- t reated  group (dog 3, Tab le  I). However ,  no 
po lymorphonuc lear  leukocytes  were seen in the 
synov ia l  membrane,  as wou ld  have  been expected  
in the presence  of super imposed bacter ia l  in fect ion  
of  the  jo int .  
In  cont ras t  to the changes  in the OA knee,  
synov ium from the  cont ra la tera l  knee  of every  
an imal  was  gross ly  smooth  and  g l i s ten ing ,  w i th  no 
ev idence  of th icken ing  or hyperemia .  The dens i ty  
of  mononuc lear  cel ls in synov ium from the 
cont ra la tera l  knee  of d iacerhe in - t reated  group was 
1600 + 1200 cel ls  per  mm 2, whi le  that  in the  
samples  from the unt reated  dogs was 1200 +_ 800 
cel ls  per  mm 2 (Table I). 
In  severa l  cases, extens ive  loss of a r t i cu la r  
car t i l age  in the  OA jo in t  (see below) was 
accompan ied  by the  presence  of car t i l age  shards  in 
the  synov ia l  membrane (Table  I). However ,  the 
preva lence  of car t i l age  shards  in the  two t reatment  
groups  was comparab le .  
OSTEOPt tYTES 
In  six of the  seven unt reated  dogs, la rge  
os teophytes  were seen on the  media l  or  la tera l  
pate l la r  r idge,  or  both  (Table  II). Osteophytos i s  
Table II 
Gross morphologic changes of OA in the unstable knee 
Treatment 
group 
Osteophytes* 
Inter- 
Trochlear ridge Femoral condyle condylar 
Dog ..................... 
number Med Lat Med Lat Notch 
Full-thickness 
carti lage ulceration]" 
Tibial Trochlear Femoral 
plateau ridge condyle 
Med Lat Med Lat Med Lat 
DAR 
Untreated 
1 0 + 0 0 ++ + ++ 
2 +++ ++ + 0 + ++ ++ 
3 ++ ++++ 0 0 ++ +++ +++ 
4 +++ +++ 0 0 +++ ++ +++ 
5 ++ + 0 0 0 ++ ++ 
6 ++ +++ ++ 0 0 ++ ++ 
7 ++++++++ + 0 + ++ ++ 
8 +++ ++++ 0 0 ++ +++ + 
9 ++++ +++ 0 0 + ++ ++ 
10 +++ ++ 0 0 + ++ ++ 
11 0 +++ 0 0 0 + + 
12 0 +++ 0 0 + ++ ++ 
13 ++++++++ 0 0 + +++ ++ 
14 0 0 0 0 0 0 0 
XX o XX 0 
X o o o 
X o X 0 
X o 0 o 
X o o 0 
XX o xx  0 
X o 0 o 
X o 0 o 
X o 0 0 
X o 0 o 
X o 0 0 
XXX 0 XX o 
X o X 0 
XXXX XXXX XXX XXX 
Med, Medial; Lat, Lateral. 
*0-  no osteophytes, + = no more than three small osteophytes, + + = moderate osteophytosis, + + + = marked osteophytosis, 
+ + + + = extensive, large osteophytes. 
t0 = no ulcer, X = ulceration encompassing up to 24% of the surface of the ridge or condyle, XX = ulceration encompassing 25-49% of 
the surface, XXX = ulceration of 50-74% of the surface, XXXX = ulceration of > 75% of the surface. 
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FIG. 1. (a) Specimens from dog 14 in the untreated control group. Note the full-thickness ulceration of articular 
cartilage involving virtually all of the medial and lateral trochlear idge and both femoral condyles of the OA knee. 
The contralateral knee is grossly normal. (b) Specimens from dog 6 in the DAR-treatment group, showing moderate 
ulceration of the medial trochlear idge and medial femoral condyle of the OA knee. The contralateral knee is grossly 
normal. Although cartilage ulceration tended to be less severe in the DAR group than in the untreated controls, the 
difference was not statistically significant. 
was as prevalent,  but tended to be somewhat  less 
marked, on the t ibial p lateau and intercondylar  
notch. No str iking differences in either the extent 
of osteophytosis or size of osteophytes were noted 
upon comparison of the diacerhein t reatment  
group and the controls. 
Notably, dog 14 in the untreated group exhibited 
no evidence of osteophytosis; as seen in Table II, 
ful l-thickness ulcerat ion of the art icular  cart i lage 
was more extensive in this animal than in any of 
the others in the series. 
FULL-THICKNESS CARTILAGE ULCERATION 
As seen in Table II, ful l-thickness ulcers of the 
art icular  cart i lage were present on the medial  
t rochlear  idge of the unstable knee of every dog. 
Although these ulcers varied in size, in none of the 
seven diacerhein-treated dogs did they involve 
more than 50% of the surface of the medial  
t rochlear  ridge; in contrast,  in two of the seven 
untreated control  dogs ful l-thickness cart i lage loss 
was seen over at least 50% of the medial  t rochlear  
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ridge. Ful l-thickness ulcers were less common on 
the medial femoral condyle than on the medial 
t rochlear idge (Table II) of the OA knee, but were 
seen in three diacerhein-treated dogs and three 
untreated dogs. 
GROSS CARTILAGE F IBR ILLAT ION 
Fibri l lat ion of the art icular  surface of the medial  
femoral condyle of the OA knee was apparent  in all 
untreated ogs and was at least moderately severe 
in six of the seven dogs in this group. In contrast, 
in one dog in the diacerhein group the cart i lage 
surface at this site was intact and in three other 
diacerhein dogs fibril lation was only minimal or 
mild. On the other hand, cart i lage fibri l lation on 
the medial patel lar  ridge tended to be severe and 
extensive in both t reatment  groups. 
HISTOLOGIC  SEVERITY  OF  OA CHANGES IN  THE 
ART ICULAR CARTILAGE 
In one diacerhein-treated dog and two dogs in 
the untreated group, ful l-thickness ulcerat ion of 
the cart i lage of the unstable knee on the central  
weight-bearing region of the medial femoral 
condyle precluded sampling from the designated 
site for histologic examination.  The mean Mankin  
score of the cart i lage samples obtained from the 
other six dogs in the diacerhein group was 4.6, 
whereas that  for the five samples of OA cart i lage 
from the untreated ogs was 6.8 (P= NS). In every 
case cart i lage from the corresponding region of the 
contra latera l  knee was histological ly and histo- 
chemical ly normal. 
CARTILAGE WATER CONTENT AND URONIC  ACID 
CONCENTRATION AND NET RATE OF PG SYNTHESIS  
As described previously [11], the water content 
of cart i lage from the OA knee was approximately  
9% higher than that  of cart i lage from the 
contra latera l  knee (Table III). However, no 
difference in cart i lage water content was apparent  
upon comparison of the two t reatment  groups. 
In both the diacerhein-treated ogs and the 
untreated dogs, the uronic acid concentrat ion 
of cart i lage from the OA knee was comparable 
with that  of cart i lage from the contra latera l  
knee (99.4 + 19.6%, 96.1 + 37.6%, respectively) 
(Table III). 
In both t reatment  groups, the values for net 
3sSO4-PG synthesis varied considerably from 
animal to animal. Although the net rate of (PG) 
synthesis in OA cart i lage from one of the untreated 
dogs (dog 11) was 22% higher than that  in the 
contra latera l  knee, the mean rate of PG synthesis 9 
in OA cart i lage for the untreated group as a whole 
was lower than that  in cart i lage from the 
contra latera l  knee (74.6 + 29.6%); indeed, in two 
untreated dogs (dogs 12 and 14, Table III) PG 
synthesis by the OA cart i lage was only about 35 
Table III 
Compositional analysis of the cartilage and net rate of ~5SOr synthesis 
Treatment 
group 
Water content, 
% of dry weight 
Uronic acid concentration 
gg/ml wet weight 
Knee Knee :3'~S04 PG 
Dog OA/CK OA/CK synthesis 
number CK OA x 100 CK OA x 100 OA/CK x 100 
DAR 
Mean 
! S.D. 
Untreated 
Mean 
• S.D. 
1 67.5 71.7 106.2 3.6 3.6 100.0 82.0 
2 64.6 72.9 112.8 3.6 4.3 119.4 72.2 
3 66.3 69.9 105.4 3.6 3.5 97.2 92.7 
4 65.3 73.0 111.8 4.5 5.6 124.4 155.7 
5 66.5 71.8 108.0 5.0 5.2 104.0 76.1 
6 68.0 77.0 113.2 3.8 2.6 68.4 97.1 
7 65.2 70.5 108.1 3.9 3.2 82.1 78.8 
109.4 99.4 93.5 
3.2 19.6 28.8 
8 66.6 73.6 110.5 3.8 2.0 52.6 72.3 
9 71.7 67.6 94.3 2.2 2.7 122.7 94.5 
10 67.9 76.7 113.0 4.1 3.0 73.2 81.6 
11 66.9 71.0 106.1 3.5 5.2 148.6 122.5 
12 61.4 72.8 118.6 3.1 3.2 103.2 35.2 
13 67.3 72.6 107.9 3.4 4.1 120.6 72.2 
14 71.1 77.7 109.3 5.2 2.7 51.9 43.6 
108.5 96.1 74.6 
7.5 37.6 29.6 
CK, contralateral knee. 
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Table IV 
Total collagenase and total gelatinase activity in extracts 
of tibial plateau cartilage 
Gelatinase Collagenase 
units* unitst 
Knee Knee 
Treatment Dog 
group number CK OA CK OA 
DAR 
Mean 
~_ S.D. 
Untreated 
Mean 
_~ S.D. 
1 ND 1.0 0.4 23.4 
2 1.9 2.7 0.0 3.9 
3 0.7 1.5 0.3 23.0 
4 1.0 1.5 0.5 1.8 
5 0.6 0.9 0.2 1.8 
6 0.1 0.8 4.1 10.5 
7 0.6 0.7 0.3 4.3 
0.7 1.3 0.8 9.8 
0.6 0.7 1.5 9.6 
8 0.3 1.4 1.3 248.6 
9 0.2 0.2 3.2 33.4 
10 0.3 0.8 1.1 9.3 
11 0.3 2.6 1.6 11.2 
12 0.2 2.0 0.8 44.6 
13 0.1 1.0 0.6 1.8 
14 0.1 1.0 1.2 10.6 
0.2 1.3 1.4 51.3 
0.1 0.8 0.9 88.3 
CK, Contralateral knee, 
%tg gelatin digested/min/g of cartilage. 
*gg collagen digested/min/g of cartilage. 
and 44%, respectively, of that in carti lage from the 
contralateral  knee. In contrast, in the OA carti lage 
from one animal in the diacerhein group (dog 4, 
Table III) PG synthesis was some 55% greater than 
that in carti lage from the contralateral  knee and, 
for the diacerhein group as a whole, the mean rate 
of PG synthesis approximated that in samples from 
the contralateral  knee (93.5 _%_+ 28.8% ). The differ- 
ence between treatment groups was not statisti- 
cally significant, however. 
CARTILAGE MMP ACTIVITY 
In both treatment groups, levels of total 
collagenase activity in extracts of carti lage from 
the OA knee were considerably greater than those 
in extracts of carti lage from the contralateral  knee 
(Table IV, P=0.018 for both groups, Wilcoxon 
test). Although the values for collagenase activity 
varied widely from dog to dog, activity in extracts 
of OA carti lage from six of the seven untreated 
dogs exceeded 5 U, whereas samples from four of 
the seven diacerhein-treated dogs contained less 
than 5 U of collagenase activity. Notably, collagen- 
ase activity was strikingly higher in dog 8 in the 
untreated OA group (Table IV) than in any of the 
other animals in this series. As noted above, the 
synovial fluid leukocyte count was also higher in 
this dog than in any of the others. However, even 
if dog 8 is omitted from the analyses, the mean 
collagenase activity in the untreated OA group 
(18.5 + 16.6 U) was nearly twice as high as in the 
group treated with diacerhein. 
Total gelatinase activity also was greater in 
extracts of carti lage from the OA knee than from 
the contralateral  knee (Table IV, P=0.043, 
P = 0.001, by t-test, in the diacerhein group and the 
untreated group, respectively). Diacerhein treat- 
merit had no apparent effect on the level of 
gelatinase activity in comparison with values for 
the untreated dogs. While the mean levels of 
gelatinase activity in extracts of carti lage from the 
contralateral  knee were low, values were higher 
in the diacerhein group than in the untreated 
group (mean=0.7_+ 0.6 U, 0.2 + 0.1 U, respect- 
ively, P=0.047, t-test). 
Stromelysin activity in samples from both the 
OA knee and contralateral  knee was no greater 
than the background level. 
It is recognized that the contralateral  knee of the 
cruciate-deficient dog is not truly normal but 
exhibits some changes in carti lage metabolism, 
presumably due to alterations in loading and in 
kinematics [37, 38]. There is no evidence, however, 
that  osteoarthrit is develops in the contralateral  
knee in this model. Previous studies have shown 
that diacerhein can stimulate PGE2 synthesis by 
normal chondrocytes in culture and can inhibit 
collagenase expression when such cells are 
stimulated by IL-1 [16-21]. In the present study, 
mean levels of gelatinase activity in extracts of 
carti lage from the contralateral  knee, although 
low (Table IV), were higher in the diacerhein 
group than in the untreated group (0.7 + 0.6 U; 
0.2 _+ 0.1 U, respectively, P=0.047, t-test). In con- 
trast, mean values for collagenase activity in 
extracts of carti lage from the contralateral  knee, 
while low in both treatment groups, were lower in 
the diacerhein group than in the untreated ogs, 
although the difference was not statistically 
significant. 
Discuss ion  
The accelerated canine model of OA employed in 
the present study produces full-thickness carti lage 
ulceration within only weeks after ACLT, 
although the earl ier changes of OA, which follow 
l igament ransection, are characterized by hyper- 
trophic repair, with an increase in PG synthesis 
that is accompanied by increases in PG content 
and PG concentrat ion of the OA carti lage [39]. In 
the late stages of the disease, however, the rate of 
PG synthesis falls to a level no greater, or lower, 
than that in the contralateral  knee [12]. We have 
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shown that oral administration of doxycycline can 
prevent he development of OA in this model [14]. 
Furthermore, therapeutic administration of this 
drug, i.e., with initiation of treatment delayed until 
cartilage lesions of OA were already established, 
was effective in preventing progression of joint 
damage [15]. On the other hand, intra-articular 
injections of glucocorticoid did not protect against 
joint damage in this model and resulted in a 30% 
decrease in the uronic acid concentration of the 
OA cartilage (Brandt K, Smith G, Albrecht M, 
unpublished observations). 
In the present study, PG synthesis in cartilage 
from the OA knee of the untreated ogs was only 
about 75% of that in the contralateral knee, and in 
two of the untreated animals the level of synthesis 
in OA cartilage was only about 35-45% of the 
value for the contralateral knee. In contrast, in the 
diacerhein-treated group PG synthesis by the OA 
cartilage tended to be maintained at a higher level 
than in the untreated controls. Except in one 
animal, however, PG synthesis was not signifi- 
cantly greater than that in the contralateral knee. 
Furthermore, the level of net 35SO4-PG synthesis in 
the diacerhein group did not result in a uronic acid 
concentration greater than that in OA cartilage 
from the untreated ogs. 
Although diacerhein treatment appeared to 
reduce the severity of gross cartilage fibrillation 
on the medial femoral condyle, and perhaps, also 
the extent of full-thickness ulceration on the 
medial trochlear idge of the unstable knee, these 
changes were not statistically significant in 
comparison with the untreated OA dogs. The 
failure to demonstrate a clear DMOAD effect of 
diacerhein in this study may have been due to the 
relatively small sample size and the large variation 
in severity of pathologic hanges from animal to 
animal. Nonetheless, it is notable that diacerhein 
treatment appeared to decrease the volume of 
effusion in the OA knee and the level of 
collagenase activity in extracts of the OA 
cartilage, in comparison with the untreated ogs, 
although the effect was not statistically signifi- 
cant. Pujol [20] has previously shown that 
diacerhein protects against IL-l-induced degra- 
dation of articular cartilage matrix. Cruz [40] has 
reported that diacerhein inhibits the expression of 
IL-l-induced collagenase and stromelysin, and has 
suggested that this effect is due to inhibition of the 
binding of activated c-fos and c-jun to the AP-1 site 
on the collagenase and stromelysin promoter 
region. It appears relevant, therefore, that the 
DMOAD effect of doxycycline, which was demon- 
strable in the canine model employed in the 
present study, is associated with reductions in the 
levels of total and active collagenase and 
gelatinase in extracts of the OA cartilage [14, 15]. 
It should be noted that MMP levels in the 
present study were determined on the basis of 
activities against defined substrates and could, 
therefore, have been affected by concurrent 
changes in the level of endogenous inhibitors, e.g., 
TIMP which would not have affected measure- 
ments of the level of enzyme protein, e.g., by 
immunoassay or by use of zymograms in which 
TIMP is dissociated from active enzyme. 
Finally, it is important o consider that the 
changes associated with the initiation of OA may 
be different from those associated with progression 
of the disease [41]. The possibility must be 
considered that DMOADs, which are effective in 
the stage of initiation, may not be effective at a 
later stage of the disease, and vice versa. Although 
diacerhein administration i the present study did 
not result in a statistically significant DMOAD 
effect, the several differences noted above between 
the diacerhein group and the untreated OA dogs 
suggest activity of the drug in the OA model 
employed herein. It is possible that a DMOAD 
effect of diacerhein might be more clearly 
discernible with a larger number of animals per 
treatment group or in a less rapidly progressive 
model of OA. Consistent with the latter possibility, 
intra-articular glucocorticoid administration in 
the accelerated canine model, as noted above, 
conferred no protection against joint damage, 
whereas uch treatment was found to have a clear 
DMOAD effect in a much more slowly progressive 
cruciate deficiency canine model of OA [42]. 
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